synthetic polymers, such as PEG 13, 23 . Although collagen type I gels effectively recapitulate the properties of connective tissues and Matrigel enables researchers to conduct cell growth and differentiation studies 17 , hydrogels derived from natural proteins often lack consistent properties and contain impurities, resulting in high batch-to-batch variation 16 . Hence, researchers in the field of materials science have developed an array of synthetic hydrogels that are widely explored as 3D ECM mimics 26 . Although these synthetic polymers have the advantage of reproducible, well-defined and tunable physico-chemical properties, they lack the cell-binding and protease-cleavage motifs that are naturally found in ECM. This limitation can be overcome by adding cellresponsive sites, such as integrin cell-binding motifs, to synthetic polymers, thus engineering biomimetic materials 27 .
Interestingly, other 3D cell culture approaches use scaffolds instead of hydrogels. For example, the work by the Cukierman group 28 introduced cell-derived matrices as a 3D culture and assay system with the characteristics of basement membrane-like substrates in order to analyze cell morphology and behavior. To create a specific type of basement membrane, the Lengyel team 29 developed an in vivo-like tumor microenvironment by layering mesothelial cells onto an omental basement membrane. This omental basement membrane is generated by mixing ECM proteins, including collagen type I, with primary fibroblasts in order to study ovarian cancer cell functions during metastasis 29 . Such a 3D culture approach for ovarian cancer represents an organotypic model that can be further expanded with other tissue-specific cell types that are present in the tumor microenvironment, and it enables the high-throughput screening of novel therapeutics 30 . Other approaches include the combined silk-collagen scaffolds developed by the Kaplan group 31 to build a brain-like tissue, in which the biphasic architecture enables the spatially controlled growth of a neuronal network, thus mimicking the 3D morphology of the brain cortex. Other scaffold technology platforms enable researchers to monitor oxygen levels and determine hypoxia in a 3D cell culture setup 32 , as well as to investigate mechanisms that are altered during bone metastasis in patients with prostate cancer 33 .
GelMA-based hydrogels as cell culture platforms that mimic ECM Our 3D cell culture technology platform, as described here, focuses on a semisynthetic biomaterial that integrates the advantages of the aforementioned hydrogel types by harboring both integrin cell-binding and protease-cleavage sites, as well as chemically active substituents that ensure that the biomaterial has reproducible and tunable properties. These properties in combination enable cell adhesion and proteolytic degradation to take place, and they afford the ability to control the mechanical and biochemical characteristics of the hydrogels. Using GelMA-based hydrogels, we established a 3D ECM mimic that can be used to conduct a wide range of experimental and animal studies, as well as to implement quantitative cell biology applications.
Here, we describe a step-by-step protocol for the production of GelMA and for the preparation of cell-laden hydrogels that can be used as 3D culture systems for cancer and stem cell research, as well as for tissue engineering applications. We also describe validation protocols for characterizing the degree of GelMA functionalization and the mechanical properties of differently cross-linked hydrogels, which are key factors in influencing the behavior of encapsulated cells. Finally, we demonstrate various applications for cell biological assays, including visualization of cell morphology, detection of cell viability and proliferation, and total RNA extraction. We also demonstrate the use of these hydrogels as cell-delivery vehicles for different animal studies and for the cardiomyocyte microchannel approach.
Development of the protocol
GelMA is prepared from gelatin, a soluble polypeptide mixture of denatured and partially hydrolyzed collagens derived from animal tissues, such as skin, tendons and bones 34 . The main component of gelatin is collagen type I (ref. 34) . Depending on the hydrolysis processing conditions and tissue sources, a variety of gelatin products exist, which have slightly different compositions. According to our unpublished (performed by C.M. and T.J.K.) qualitative proteomic analysis, gelatin and GelMA mainly contain collagen types I and III, but they also contain traces of other collagen types. Although this approach is not covered in this protocol, collagen type IV (and its methacryloyl-substituted derivative) can be added to GelMA-based hydrogels with control over its concentration, enabling researchers to implement a variety of cell-specific applications.
Pure gelatin is water soluble, and it forms thermo-reversible transparent hydrogels via physical interactions between collagen molecules 35 . However, this type of physical hydrogel is not stable at body temperature, and it does not allow researchers to control and fine-tune its properties. To obviate these drawbacks, gelatin has been chemically functionalized with unsaturated methacryloyl groups to result in GelMA, which forms covalently cross-linked hydrogels by photo-initiated polymerization under mild conditions 35, 36 and enables cell encapsulation with high viability 10, 37 . Recent data from our research groups suggest that GelMA prepared according to the protocol described herein contains a mixture of methacrylamide and methacrylate groups, although the methacrylamide groups are the majority (>90% of all the methacryloyl groups present in the hydrogel) 38 . As a result, terms that were widely used to describe this material in the literature, such as gelatin methacrylamide, gelatin methacrylate or methacrylated gelatin, are not chemically accurate. Instead, we suggest using the GelMA is dissolved in PBS at 37 °C and mixed with the photo-initiator to obtain the precursor solution. Cells, and optionally hyaluronic acid methacrylate (HAMA; indicated by a dashed line), are added to the precursor solution before casting it into a custom-made Teflon mold. The casting mold is then covered with glass slides and transferred into a UV cross-linker to enable the formation of the hydrogel by photo-polymerization. By using a custom-made cutting guide, the hydrogel stripes thus obtained are cut into constructs of equal size (4 mm × 4 mm × 2 mm), and can be used for biological assays and as a cell delivery vehicle for animal studies. term 'gelatin methacryloyl' to reflect the coexistence of both methacrylamide and methacrylate groups in GelMA 38 .
The mechanical properties of GelMAbased hydrogels are readily tunable by varying the degree of methacryloyl substitution, polymer and photo-initiator concentrations, and photo-cross-linking time 35, 39 . Specific physical or otherwise hydrogel characteristics are discussed in the Experimental design section below. The quantitative links between these factors and the predictable mechanical characteristics of the resulting hydrogels 10, 37 are taken into consideration in our detailed relevant validation procedure. This protocol demonstrates a user-friendly and highly reproducible procedure to prepare GelMA-based hydrogels using a custom-made Teflon casting mold, which enables matrices with reproducible biochemical compositions, sizes and mechanical properties to be obtained. The resulting hydrogels are suitable for different biological assays and as cell delivery vehicles (Fig. 1) . In addition, we describe how the covalent incorporation of methacryloyl-functionalized ECM components, such as hyaluronic acid methacrylate (HAMA), yields complex ECM-mimicking matrices that can be adapted to act as tissue-specific model systems.
Applications
Our groups' modular tissue culture platform is of prime interest, not only to biomedical engineers and biomaterial scientists but also to cell and molecular biologists working on applying novel biomaterial-based technology platforms to cancer research, and more generally to in vitro disease models, tissue engineering and regenerative medicine. We have demonstrated that GelMA-based hydrogels prepared according to our protocol (Fig. 2) can serve as 3D model systems for studies on ovarian (Fig. 3) , breast (Fig. 4) and prostate cancers 33 , as well as for cartilage tissue engineering 10 . In expanding the applicability of the GelMA toolbox, we developed different hydrogel formulations to generate hybrid hydrogels with varying chemical, biological and mechanical properties, which enable the differentiation of stem cells to desired cell types as well as the formation of vascular networks (Fig. 5 ) 40 . Integration of microchannels into these hydrogels can further stimulate vascular network formation 41 . Moreover, GelMA-based hydrogels have been used as an injectable gene delivery system to stimulate vasculogenesis for myocardial therapy 42 .
In the context of cancer research, cell-ECM interactions mediate critical steps in cancer progression and drug responses 18 . GelMA-based hydrogels were successfully used to develop a 3D cell culture model that allows the formation of multicellular spheroids from single ovarian cancer cells, which is the initiating process during peritoneal metastasis 37 . Variation of hydrogel stiffness resulted in changes of the cell morphology, metabolic activity and proliferation rate 37 . In addition, this spheroid-based approach was applied to an ovarian cancer animal model (Fig. 3) . Cell-laden hydrogels were implanted intraperitoneally into nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice. Tumor formation occurred 4 weeks after implantation, which enabled the administration and screening of a clinically used chemotherapeutic, paclitaxel, over 4 weeks. A paclitaxel response of 63% was detected (Fig. 3) ; this value is comparable to that determined in our previously published study using GelMA-based hydrogels 37 as cell delivery vehicle for ovarian cancer cells in vivo. Similarly, metastatic breast cancer cells have been embedded within GelMA-based hydrogels, and they showed high cell viability over the duration of 3D cell culture (Fig. 4) . These cell-laden hydrogels were then implanted in close proximity to a humanized tissue-engineered bone construct to mimic invasion of the humanized bone by the breast cancer cells (Fig. 4) . Hence, this method provides an approach to study breast cancer bone colonization in vivo 43 .
In the context of tissue engineering and regenerative medicine, coculture of human blood-derived endothelial colony-forming cells (ECFCs) and human bone marrow-derived mesenchymal stem cells (MSCs) encapsulated in GelMA-based hydrogels supported extensive formation of a 3D capillary-like vascular network in vitro (Fig. 5) . The coculture of ECFCs and MSCs can be further expanded by coculturing endothelial cells with pericytes or smooth muscle cells. Importantly, functional anastomoses between the newly formed vascular network in vitro and the native vasculature upon implantation into male athymic nude (nu/nu) mice were observed, indicating potential regenerative applications 40 . By combining microfluidic systems with GelMA-based hydrogels, GelMA pre-polymers can be readily used to coat these microchannels. After photo-cross-linking, the hydrogel coating layer stimulates functions such as cell adhesion and alignment within the microchannels, suggesting that these hydrogels are uniquely qualified for organ-on-a-chip applications, such as used for cardiomyocyte cultures (Fig. 6) . Cardiomyocytes are elongated along the flow direction growing with cardiac fibers aligned inside the microchannels (Fig. 6) . This cardiomyocyte microchannel approach represents an in vitro model for diagnosis and drug-screening applications, owing to the widely known advantages of organ-on-a-chip models, including feasible control of the cellular microenvironment, delivery of nutrients and chemical cues to the cells through continuous medium perfusion, and reduction of the amount of reagents and cells during experiments 44 . Many studies described in the literature are stand-alone demonstrations of a specific biomaterial or a combination of different methods into a 3D model for a single application, but a modular tissue culture platform is still lacking 16 . Our protocol covers the complete manufacturing process, including polymer functionalization, standardized preparation of 3D cell cultures, and the application and characterization of cell-laden hydrogels, for use in cancer research, stem cell research and tissue engineering. This broad spectrum of biomedicine-based research provides the much-needed continuity that will enable researchers to cross-validate different applications, a feature that is desperately needed in the area of 3D ECM mimics 26 .
Limitations
GelMA-based hydrogels can cover a wide spectrum of physicochemical properties by varying key parameters and factors in the hydrogel formulation, photo-cross-linking conditions and incorporation of additional ECM components to generate a library of hydrogels. The protocol described herein thus serves as a basis for further optimization, depending on the encapsulated cell type and targeted culture model.
The surface properties of a wide variety of hydrogels that are commonly used for 3D cell culture applications, including GelMA, are highly dependent on the properties of the substrate on which it is cross-linked. Even for the same chemical structure, a hydrogel prepared on a hydrophobic substrate, such as Teflon, exhibits a lower cross-linking density at its surface than a hydrogel prepared on a hydrophilic substrate 45 . This effect has been largely neglected in the literature, yet it can be observed in a wide variety of hydrogels, including those that are commonly used for 3D cell culture applications, such as PEG, and, to a far lesser extent, GelMA. Although the effects of the cross-linking substrate on the bulk hydrogel physico-chemical properties are negligible for thick constructs (e.g., 2 mm), thin GelMA-based hydrogels (e.g., 1 mm) prepared on Teflon show increased swelling and lower compressive moduli compared with thick constructs (Fig. 7) . As this substrate effect only occurs at the immediate surface of the hydrogel, the bulk mechanical and swelling properties of thick hydrogel constructs remain unaffected by the properties of the substrate. Therefore, it is recommended to consistently use a standardized protocol and identical experimental conditions to ensure reproducibility.
Another limitation is the necessity to optimize the hydrogel composition to encapsulate more biologically sensitive cells, such as endothelial cells, with high viability. As described herein, these cell types require a low degree of GelMA functionalization and a low cross-linking density of the GelMA-based hydrogel to achieve physiological cell behavior.
Experimental design
A GelMA-based hydrogel experiment can be designed by combining some of, but not necessarily all, the procedures described below. GelMA functionalization, dialysis and lyophilization will need to be included in any experimental study (Steps 1-11), as well as preparation of GelMA precursor solution and hydrogel construct (with or without encapsulated cells, Steps 14-26). It is highly recommended that characterization of GelMA functionalization be performed on every newly synthesized and purified batch, to ensure that the intended degree of methacryloyl substitution has been obtained (Steps 12 and 13). Mechanical testing is highly recommended as a functional quality control test to ensure agreement between batches and experiments (Steps 27-36). In addition, mechanical testing can be an assessment of degradation or tissue formation studies. Microscopy imaging will be part of most 3D cell cultures (Step 37), as will the assessment of cell viability and proliferation (Steps 38 and 39). Total RNA extraction from GelMA-based hydrogels can be performed when interested in the gene expression of encapsulated cells grown in 3D (Steps 40 and 41).
Hydrogel casting mold. Photo-polymerization of the GelMA precursor solution is performed in a casting mold made of Teflon (polytetrafluoroethylene, PTFE). In our laboratory, we use a mold to produce hydrogel strips with the dimensions of 50 mm × 4 mm × 2 mm (length × width × height), which are cut into smaller units of 4 mm × 4 mm × 2 mm (length × width × height) using custom acrylic cutting guides and a scalpel after photo-polymerization ( Figs. 1 and 2 ). Before commencing with the procedure outlined in this protocol, it is recommended to manufacture Teflon molds and laser-cut the cutting guides needed for the preparation of GelMA-based hydrogels as per technical drawings provided in the Supplementary Figures 1  and 2 . Note that the design of both the mold and cutting guides may be customized to produce hydrogels of different shapes and sizes, depending on your experimental needs.
Tailoring mechanical properties of GelMA-based hydrogels.
As indicated earlier, the mechanical properties of GelMA-based hydrogels can be tailored by variation of one or more of the following factors: the degree of functionalization (DoF), the polymer and photo-initiator concentrations, as well as photocross-linking time. For example, the DoF directly influences the highest achievable cross-linking density of the hydrogel matrix, and ultimately the hydrogel porosity and mechanical properties. When other factors remain unchanged, increasing the DoF leads to stiffer hydrogels with a higher cross-linking density and improved shape fidelity 39 , whereas the pore size decreases 40 . Increasing the polymer concentration or photo-cross-linking time generally yields stiffer hydrogels 39 . These factors can be varied within a large range without affecting handling or compromising cell viability and function, but it should be optimized for each cell type. Changes to the photo-initiator concentration will affect the cross-linking kinetics, and a shorter photo-cross-linking time may be required to yield hydrogels with comparable mechanical properties when the initiator concentration is increased. Increasing the photo-cross-linking time leads to a higher cross-linking density and stiffness, both of which plateau when the hydrogel is fully cross-linked. For a detailed description of how the above-mentioned factors influence hydrogel properties, refer to our previously published work 39 . It is recommended that the parameters summarized in Table 1 be used as a basis for further optimization.
Avoiding oxygen inhibition of photo-initiated polymerization.
Oxygen is known to affect the photo-initiated polymerization of Compressive moduli of cell-free GelMA-based hydrogels prepared in Teflon molds with either 1 or 2 mm depth were determined after incubation in PBS at 37 °C overnight (mean ± s.e.m.; n = 6), and they differ significantly (P < 0.001).
(b) Effective hydrogel swelling was determined by weighing GelMA-based hydrogels immediately after cross-linking and again after swelling in PBS at 37 °C overnight and changes significantly (P < 0.001) with the casting mold depth. The difference in wet weights, before and after swelling, was expressed as a percentage (mean ± s.e.m.; n = 6). acrylate and acrylamide-based chemistries 46 . Thus, the degree of photo-cross-linking and mechanical properties of the hydrogels can be compromised by the influx of oxygen during hydrogel photo-polymerization. It is therefore necessary to remove existing air bubbles and to cover the hydrogel precursor solution with a glass slide during photo-polymerization, as outlined in the following protocol, as well as depicted in Figures 1 and 2 .
Degassing of the hydrogel precursor solution is not necessary.
Photo-polymerization of GelMA-based hydrogels. UV-initiated cross-linking of cell-laden hydrogels is a commonly applied method, and, to our knowledge, no major adverse effects on cell viability and function have been reported, despite its extensive use with diverse cell types, including primary cells. The damage that UV light may cause is highly dependent on its wavelength and the nature of the radicals it creates. As DNA has an absorption maximum of 260 nm, it is recommended that a wavelength of 365 nm be used to minimize the risk of direct DNA damage. Our most recent results suggest that radicals generated by UV exposure preferentially react with the unsaturated methacryloyl groups of GelMA, which therefore have a cell-protective effect 47 .
As a result, cell viability and function are not compromised by UV-initiated cross-linking 47 .
Co-polymerization of methacryloyl-substituted ECM components for tissue-specific 3D models. To yield tissue-specific 3D models, methacryloyl-substituted ECM components may be co-polymerized with GelMA. For example, for human articular chondrocyte cultures, hyaluronic acid can be functionalized with methacrylate groups by reaction with methacrylic anhydride to yield HAMA, which enables the covalent and stable incorporation of hyaluronic acid into the hydrogel matrix and was shown to enhance chondrogenic cell differentiation, accumulation of cartilaginous ECM and mechanical properties in articular cartilage tissue engineering applications when compared with GelMA alone 48 . The GelMA concentrations recommended for in vitro chondrogenesis are within the physiological range of the collagen content of human articular cartilage. The mean (range) content of collagen type II in normal human articular cartilage is 14% (9.2-20.8%; weight per wet weight) 49 , which is very similar to the 10% typically used in our experiments 48 . Although it is not specifically outlined in the following protocol, this principle can also be applied to other relevant ECM components to study their effects on cellular behavior.
Mechanical testing of GelMA-based hydrogels. To perform unconfined compression tests (Fig. 7) , in our laboratory, we are using a custom-manufactured immersion bath comprising an aluminum block with a rectangular recess, which is capable of holding up to 25 ml of buffer for the mechanical testing of hydrogels. Beneath this recess, the aluminum block features a longitudinal feed-through with tubing attachments on either side, which allows perfusion with temperature-controlled water using an aquarium water pump, tubing and a conventional laboratory water bath. ; store it at 4 °C) Triton X-100 (Sigma-Aldrich, cat. no. X100; store it at RT) Glycine (Sigma-Aldrich, cat. no. G8898; store the powder at RT, and store the solution at 4 °C) Fig. 1 )  crItIcal Clean the Teflon mold with warm water and sterilize it with 70% (vol/vol) ethanol before use; autoclaving may damage the mold. Untreated microscope glass slides  crItIcal Ensure that the same brand or type of glass slides is used consistently in order to exclude variation of hydrogel properties due to different light permeation through different glass slides. Medium for human ovarian cancer OV-MZ-6 cell culture Prepare high-glucose (4.5 g/l) DMEM supplemented with 10 mM HEPES, 50 U/ml penicillin, 50 µg/ml streptomycin, 20 µg/ml gentamycin, 10% (vol/vol) FBS,
0.550 mM l-arginine and 0.272 mM l-asparagine. This medium can be stored at 4 °C for 4-6 weeks. Human articular chondrocytes Isolate these cells from the full-thickness cartilage of patients undergoing total knee replacement surgery for osteoarthritis, as described elsewhere 10 . Cells encapsulated in GelMA-based hydrogels are cultured in high-glucose (4.5 g/l) DMEM supplemented with 10 mM HEPES, 50 U/ml penicillin, 50 µg/ml streptomycin, 0.1 mM MEM non-essential amino acids, 2 mM GlutaMAX, 0.4 mM l-proline (freshly added at each medium change), 0.1 mM l-ascorbic acid, ITS-G (1:100), 1.25 mg/ml BSA, 10 ng/ml TGF-β3 and 0.1 µM dexamethasone. This medium can be stored at 4 °C for 4-6 weeks. Human ECFCs Isolate these cells from the mononuclear cell fraction of human cord blood samples, as described elsewhere 40 . Cells are expanded in EBM-2 supplemented with SingleQuots, 50 U/ml penicillin, 50 µg/ml streptomycin, 2 mM GlutaMAX and 20% (vol/vol) FBS. This medium can be stored at 4 °C for 4-6 weeks. Human MSCs Isolate these cells from the mononuclear cell fraction of human bone marrow samples, as described elsewhere 40 . Cells are expanded in MSC growth medium supplemented with 50 U/ml penicillin, 50 µg/ml streptomycin, 2 mM GlutaMAX, 10% (vol/vol) FBS and 10 ng/ml bFGF. This medium can be stored at 4 °C for 4-6 weeks. Sodium citrate buffer for ninhydrin assay Prepare a sodium citrate monobasic 0.5 M solution in demineralized or UltraPure water (107 mg/ml), and adjust the pH to 5.5 using 1.0 M HCl. Prepare the solution as required, and store it according to the manufacturer's instructions. Solutions for CLSM Prepare a 10 mg/ml stock solution of FDA in PBS by dissolving 1 g of FDA in 1 ml of PBS, and store it protected from light at −20 °C (can be stored for at least 1 year). Prepare a 4% (wt/vol) solution of PFA dissolved in PBS, and store it at −20 °C (can be stored for at least 1 year). Prepare a glycine 0.1 M solution in PBS and store it at 4 °C (can be stored for 1-2 months). Prepare a 1% (wt/vol) solution of BSA in PBS by dissolving 1 g of BSA in 100 ml of PBS, and store it at 4 °C (can be stored for 1-2 months). Prepare a 5 mg/ml stock solution of DAPI in PBS by dissolving 10 mg of DAPI in 2 ml of PBS, and store it protected from light at −20 °C (can be stored for at least 1 year). It is recommended that the following solutions be filter-sterilized using 0.2-µm syringe filter units before use: 4% (wt/vol) PFA, glycine 0.1 M solution and 1% (wt/vol) BSA in PBS. Solutions required for CyQUANT assay Prepare phosphate-buffered EDTA (PBE) buffer containing 20 mM Na 2 HPO 4 , 30 mM NaH 2 PO 4 × H 2 O and 5 mM Na 2 EDTA in 500 ml of demineralized or UltraPure water; adjust the pH to 7.1, and autoclave the solution at 121 °C for 15 min. Make a stock solution of 100 mg of proteinase K in 10 ml of PBE buffer, and prepare a fresh final concentration of 0.5 mg/ml proteinase K in PBE buffer. Prepare 5 ml of RNase A solution per 96-well plate (180 mM NaCl, 1 mM EDTA, 4.5 ml of UltraPure DNase-and RNase-free distilled water, 0.5 ml of 20× CyQUANT lysis buffer and 1.4 U/ml RNase A stock). Prepare 10 ml of CyQUANT GR dye solution per 96-well plate (9.5 ml of UltraPure water, 0.5 ml of 20× CyQUANT lysis buffer and 50 µl of CyQUANT GR dye stock). Prepare the solutions as required, and store them according to the manufacturers' instructions. For a large reaction volume, an overhead stirrer should be used instead of a magnetic stir bar. In our laboratory, we have tested reaction volumes of up to 300 ml, corresponding to 30 g of gelatin 35 .
2|
While stirring moderately, heat the mixture to (and keep at) 50 °C in a water bath until the gelatin is fully dissolved and the solution becomes clear.
3|
While stirring vigorously, slowly add 0.6 g of methacrylic anhydride (very viscous liquid) per 1 g of dissolved gelatin for a high degree of methacryloyl functionalization. Continue stirring vigorously for 60 min. If mixing is sufficient, the solution will turn homogeneously opaque owing to the dispersion of methacrylic anhydride. Alternatively, this reaction can be run for up to 3 h; however, the reaction time and temperature, as well as the mass ratio of methacrylic anhydride to gelatin, are used determine the degree of GelMA functionalization.  crItIcal step Ensure adequate stirring during GelMA functionalization while minimizing air uptake. Insufficient stirring will lead to visible phase separation.  crItIcal step Use a glass pipette when handling methacrylic anhydride, as organic solvents may dissolve plastic pipette tips.  crItIcal step DoF can be varied by changing the ratio of methacrylic anhydride to gelatin. Use 0.6 g of methacrylic anhydride per 1 g of gelatin for a high DoF (75 ± 9% DoF 39 , as assessed using a ninhydrin assay or fluoraldehyde assay,
Step 13), or 0.06 g of methacrylic anhydride per 1 g of gelatin for a low DoF (31 ± 7% DoF, as assessed using a ninhydrin assay, Step 13) . Ultimately, the DoF will influence the cross-linking density and hence the porosity and mechanical properties of hydrogel constructs, and it needs to be chosen on the basis of the cell type used (see Experimental design and table 1).
? troublesHootInG
4|
After the reaction period, transfer the solution into 50-ml tubes, and remove unreacted methacrylic anhydride by centrifugation at 3,500g for 3 min at RT. Decant the GelMA-containing supernatant (clear solution and separated from the 'pellet') into a large (200-500 ml) glass beaker, and discard the unreacted methacrylic anhydride deposited at the bottom of the 50-ml tubes (opaque and viscous 'pellet').
? troublesHootInG 5| Dilute the supernatant solution with two volumes of preheated (40 °C), demineralized or UltraPure water.
6|
Transfer the solution to a dialysis membrane with a 12-kDa MWCO and dialyze at 40 °C against a large volume of demineralized or UltraPure water for 5-7 d in a chemical safety fume hood. Change water at least once daily. Alternatively, dialysis can be performed at 4 °C in the cold room to minimize degradation. However, this may require extended dialysis time owing to reduced diffusion at lower temperatures.  crItIcal step Methacrylic anhydride and acid byproduct are cytotoxic, and they may influence the viability of encapsulated cells. It is therefore crucial to fully remove these contaminants by dialysis before proceeding to Step 7. Dialysis is completed when the GelMA solution appears clear, and when the odor of residual methacrylic anhydride or methacrylic acid byproduct is no longer noticeable. ? troublesHootInG 7| Adjust the pH of the GelMA solution to 7.4 using 1 M NaHCO 3 .
8|
In a class II biological safety cabinet, filter-sterilize the GelMA solution using 0.2-µm syringe filter units or disposable vacuum filtration units with a PES membrane.  crItIcal step Treat GelMA and GelMA solutions as sterile after this step. ? troublesHootInG 9| Divide the GelMA solution into aliquots in 50-ml tubes and snap-freeze them in liquid nitrogen.  pause poInt Samples can be stored at −80 °C for at least 1 month.
10|
Transfer all aliquots to the freeze-dryer without allowing the solutions to thaw, and lyophilize them until the GelMA is fully dehydrated (typically 4-7 d). To maintain a sterile barrier during lyophilization, the 50-ml tubes need to be sealed with vented screw-top caps or press-fitted with 0.2-µm syringe filter units before lyophilization. Exchange vented caps or filters with standard screw-top caps after lyophilization is completed to avoid hygroscopic absorption of water during storage specified in Step 11.  crItIcal For cell culture applications, treat GelMA and GelMA solutions as sterile: work in a class II biological safety cabinet and use sealed vessels to transport GelMA-containing solutions. Clean all working surfaces with 70% (vol/vol) ethanol before commencing any procedure.  crItIcal Use a positive-displacement pipette for a viscous GelMA preparation that has a concentration higher than 5% (wt/vol). 14| Prepare at least 10 ml of fresh photo-initiator stock solution by weighing in ≥25 mg of IC2959 in a 50-ml centrifuge tube, and add PBS to a final concentration of 2.5 mg/ml. Dissolve IC2959 by placing the centrifuge tube in a water bath protocol heated to 70 °C for 5-10 min, or until it is fully dissolved. Let the solution cool to RT, transfer it to a class II biological safety cabinet and sterilize it using 0.2-µm syringe filter units. The stock concentration of IC2959 can be increased depending on the final concentration needed in Step 17.
15|
Determine the mass of GelMA required (m GelMA ) for your application based on the desired final concentration (c GelMA ) and volume (V GelMA ) using the equation m GelMA = c GelMA × V GelMA , and allow for ≥30% excess to account for losses during hydrogel preparation and to facilitate ease of pipetting. Note that V GelMA is dependent on the nominal volume of your casting mold. For example, the nominal volume of each of the four recesses of the mold used in this protocol is 400 µl (50 mm × 4 mm × 2 mm; see supplementary Figs. 1 and 2 for mold and cutting-guide design), which produces a total of 12 hydrogel constructs after cutting (Step 25). To prepare 24 hydrogel constructs, two recesses of the mold need to be filled completely with hydrogel precursor solution (Step 23), which requires the preparation of V GelMA ≥ 1,040 µl (two recesses × 400 µl × 130%).  crItIcal step The minimum total volume of the GelMA hydrogel precursor solution (V GelMA ) per hydrogel preparation should be ≥1 ml to facilitate ease of pipetting and mixing.
16| Weigh in the required amount of lyophilized GelMA, and add PBS to four-fifths of the total final volume to obtain 1.25× the final desired concentration; for example, prepare a 12.5% (wt/vol) solution of GelMA if you desire a final GelMA concentration of 10% (wt/vol).  crItIcal step If other functionalized (methacryloyl-substituted) ECM components, such as HAMA, are to be co-polymerized in the hydrogel matrix, they may be dissolved in this mixture at 1.25× the desired final concentration (if present in solid or lyophilized form). Alternatively, a concentrated stock solution of the component may be prepared in PBS and added to the mixture to obtain 1.25× the desired final concentration. Take care to adjust the volume of PBS to be added to the lyophilized GelMA accordingly, so that all functionalized components are present at 1.25× the final concentration after this step.
17|
Add the IC2959 stock solution prepared in Step 14 to a final concentration of 0.05% (wt/vol), in one-fifth of the total reaction mixture volume (see also Step 16) . Optionally, the final concentration of IC2959 can be varied to 0.5% (wt/vol) as desired, which will have an influence on the cross-linking kinetics and mechanical properties but not on cell viability. For recommended IC2959 concentrations, refer to table 1.
18|
Allow the GelMA/IC2959 mixture to soak into the solvent protected from light at 4 °C overnight.  crItIcal step GelMA foam needs to be fully immersed into the solvent to enable the complete hydration of GelMA.
cell encapsulation and hydrogel construct preparation • tIMInG 3-5 h 19| Sterilize the Teflon casting mold, acrylic hydrogel cutting guides and glass slides by spraying them with 70% (vol/vol) ethanol in a class II biological safety cabinet.  crItIcal step Ensure that the equipment has fully dried before use.
20|
Transfer the tube containing the soaked GelMA foam with IC2959 to a water bath or a cell culture incubator at 37 °C, and allow GelMA to fully dissolve over ~3 h or until the mixture turns clear. Place the tube on a shaker/rocker or manually agitate the solution occasionally to accelerate the dissolution of GelMA.
? troublesHootInG 21| When GelMA is fully dissolved and the Teflon casting mold, cutting guides and glass slides have dried entirely, detach the cells of choice-e.g., OV-MZ-6, chondrocytes, ECFCs or MSCs-according to your laboratory's standard protocol, wash the cell pellet with PBS to remove traces of trypsin or Versene, resuspend the pellet in a suitable volume of medium (5 or 10 ml) and determine the cell concentration (c suspension ) using a hemocytometer or cell counter. 
26|
Transfer individual cell-laden hydrogel constructs into a suitable cell culture medium (dependent on the cell type; see Reagent Setup) in a multiwell plate (Fig. 2) , and maintain them in a cell culture incubator at 37 °C. If you wish to perform mechanical testing of GelMA, proceed to Step 27; some commonly used cell analysis techniques are described from Step 37 onward.  crItIcal step If IC2959 concentrations above 0.05% (wt/vol) were used for photo-cross-linking, replace the cell culture medium three times at 30-min intervals to remove traces of the photo-initiator.
? troublesHootInG Mechanical testing of GelMa-based hydrogels • tIMInG 1-3 h 27| Take cell-laden hydrogels prepared as described in Steps 19-26 and/or cell-free hydrogels (without the inclusion of cells) and incubate them in a suitable buffer, such as PBS or cell culture medium, at 37 °C overnight to allow for swelling equilibration or culture cell-laden hydrogels for a desired period of time.  crItIcal step Implementation of Step 28, and those steps that follow it in the present procedure, compromises the sterility of the tested hydrogel constructs, and thus this procedure must be performed as an end-point analysis.
28| Determine the hydrogel cross-sectional area by direct measurement of hydrogel spatial dimensions (option A) or indirectly by measurement of the hydrogel wet weight and height (option B). Both options are equally valid and interchangeable for the measurement of the compressive moduli of GelMA-based hydrogel cultures by using unconfined compression tests.
(a) Direct determination of hydrogel cross-sectional area (i) Use a (digital) caliper to measure the hydrogel's length and width (rectangular hydrogel constructs) or diameter (cylindrical hydrogel constructs), and then calculate the cross-sectional area. (b) Indirect determination of hydrogel cross-sectional area (i) Remove excess buffer by carefully blotting the equilibrated hydrogel against a laboratory wipe, and determine the hydrogel's wet weight using an analytical balance. Calculate the cross-sectional area using the equation A = m/(ρ × h), in which A is the hydrogel cross-sectional area (cm 2 ), m is the hydrogel wet weight (g), ρ is the hydrogel density in g/cm 3 and h is the hydrogel height (cm); hydrogel height will be assessed in Step 35.  crItIcal step This method is commonly used, in particular for soft and odd shaped hydrogels that deform strongly when applying a caliber, but the hydrogel density needs to be measured separately. For 5% (wt/vol) and 10% (wt/vol) GelMA-based hydrogels, the density is ~1.03 and 1.05 g/cm 3 , respectively.
29|
Prepare mechanical testing equipment and the hydrogel immersion bath. Equip a vertically configured mechanical testing system (e.g., an Instron MicroTester 5848) with a nonporous indenter and a suitable load cell (e.g., 5 N-load cell), and follow the manufacturer's load cell calibration and general user instructions. The cross-sectional area of the intender must be larger than that of the hydrogel. 
30|
For immersed unconfined compression tests, prepare a suitable hydrogel immersion bath with a flat-bottom surface that allows heating to 37 °C by filling with buffer as appropriate.
31|
Determine the contact point of the indenter with the bottom surface of the immersion bath, and set this position as zero gauge length (position 0 mm).
32|
After the zero gauge length has been reset to the bottom level of the immersion bath in Step 31, raise the indenter well above the expected hydrogel height.
33|
Place the hydrogel in the immersion bath underneath the indenter.
? troublesHootInG 34| Using a ramp displacement command, lower the indenter at a rate of 0.01 mm/s, until a compressive strain of ≥15% of the hydrogel height is reached, and record the force-displacement data.  crItIcal step Initiate the linear displacement well above the hydrogel (e.g., 0.3 mm above the contact point) to allow for accurate determination of the hydrogel height and compressive strain.  crItIcal step Ensure that the hydrogel surfaces are flat and parallel to the bottom of the immersion bath.  crItIcal step For some applications that include engineering of load-bearing tissues, which undergo large amounts of physical deformation such as articular cartilage, the ultimate strength of the hydrogel constructs may be of interest.
To determine the fracture stress and strain, compress the sample until it breaks, and obtain the stress (Pa) and strain (%) values from the stress-strain curve at the point of failure.
35|
Determine the hydrogel height from the force-displacement curve, which is the point at which the force starts deviating significantly from zero.
36|
Determine the compressive modulus E c (Pa) as the slope of the linear region of the stress-strain curve between 10 and 15% hydrogel compressive strain using a linear regression analysis or the formula E c = (σ 2 − σ 1 )/(ε 2 − ε 1 ), where σ 2 is the stress at ε 2 , σ 1 is the stress recorded at force (N) divided by cross-sectional hydrogel area (m 2 ) at ε 1 , ε 2 is a strain of 0.15 and ε 1 is a strain of 0.10. ? troublesHootInG bright-field microscopy and clsM • tIMInG 3-5 h 37| If you wish to visualize the cell morphology and viability of cell-laden GelMA-based hydrogels, perform one of the following microscopic procedures 10, 37 . Collect one cell-laden hydrogel after days 1, 7 and 14 of 3D culture (or any other desired time point) for each replicate experiment. Perform microscopy of cell-laden GelMA-based hydrogels according to option A, if a lowcontrast image is sufficient (Fig. 2) , or option B, if a live-dead assessment is desired (Fig. 4) , or option C, if a high-contrast image is required (Fig. 2) , or perform all determinations in sequence during the same experiment using the same cell-laden GelMA-based hydrogel sample (if all microscopy assays are being performed, they must be performed in the order stated here). (ii) Snap-freeze the samples in liquid nitrogen (freezing facilitates the homogenization of hydrogels in the following step), and store them at −80 °C until further use.  pause poInt Samples can be stored at −80 °C for at least 1 month. (iii) Thaw the samples at RT and homogenize the hydrogels either manually, as described in Step 41A(iii), or mechanically, by loading the lysate onto a QIAshredder spin column placed in a 2-ml conical tube and centrifugation at 12,500g for 2 min at RT using a standard bench-top centrifuge.  crItIcal step Ensure best possible sample homogenization to maximize cell disruption and RNA yield. (iv) Proceed according to the RNeasy Micro kit manufacturer's instructions for the isolation and purification of total RNA.
? troublesHootInG Troubleshooting advice can be found in table 2. antIcIpateD results This protocol can be used for a variety of applications in cancer research, as well as tissue engineering and regenerative medicine. This modular technology platform provides a universal and easily adaptable 3D cell culture system that combines natural binding sites with controllable properties. All components of GelMA-based hydrogels are affordable, broadly available and easy to handle, whereas the chemical modification enables researchers to control reproducibility, physico-chemical and mechanical properties, and cellular behavior. In addition, GelMA-based hydrogel constructs can be molded into wide-ranging shapes and are easy to produce, which has proven to be a great advantage over systems such as Matrigel and collagen type I gels, and which allows for a greater variety of experimental procedures and analysis. After the GelMA functionalization procedure described herein, by using the recommended 0.6 g of methacrylic anhydride per 1 g of dissolved gelatin, an estimated DoF of 80% can be achieved. An estimated DoF of 50% is the minimum to generate 5% (wt/vol) GelMA-based hydrogels. The mechanical properties of GelMA-based hydrogels are largely dependent on the DoF, the polymer and photo-initiator concentrations, and the thermal gelation state of the GelMA precursor solution, as well as the UV exposure (intensity and time) during photo-cross-linking of the polymer network 39 . As hydrogel stiffness and cross-linking density are directly related to and strongly influence cellular behavior, mechanical characterization represents a cost-and time-effective measure of reproducibility between different GelMA batches and hydrogel preparations. Furthermore, it can also be performed to assess changes in the physical properties of the hydrogels after ECM deposition or enzymatic degradation during 3D cell culture and tissue engineering experiments. The practically achievable range of stiffness is ~1-200 kPa (ref. 39) .
Although various 3D matrices are increasingly used for cell-based studies, there are difficulties in adapting routinely used cytological methodologies to 3D cellular microenvironments. No consideration is given to the different cell architecture, cell surface area exposed or interference of the 3D matrix. Our teams have optimized the application of two quantitative assays to 3D cell cultures in which cells are embedded within different hydrogel materials 13, 23 . Cell viability and proliferation of 3D-cultured cells can be determined by performing the AlamarBlue and CyQUANT assays, respectively. Although the AlamarBlue reagent enables researchers to measure a cell's metabolic activity, results of the CyQUANT assay provide indication of cell proliferation, based on the DNA content of the cell-containing sample. Both procedures can be performed individually and independently from each other using the same cell-laden GelMA-based hydrogel sample. RNA extraction procedures, using either TRIzol reagent or a RNeasy micro kit, can be used to isolate high-quality total RNA from cells encapsulated in GelMA-based hydrogels for a variety of downstream applications, including reverse transcription real-time PCR, (micro)array analysis, whole-transcriptome analysis using next-generation sequencing, digital PCR, northern blot analysis and cDNA library constructions.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
